Clovis Oncology Inc
CLVS
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $602.06 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.18 |
| Beta | 0.22 |
| Outstanding Shares | 144,625,000 |
Return
| Return on Equity | 60.28% |
|---|---|
| Return on Assets | -72.64% |
| Return on Invested Capital | 51.53% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.22 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 4.53 |
| Enterprise Value to EBIT | -2.91 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.1 |
| Debt to Equity | -1.58 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Clovis Oncology Inc
CEO: Patrick Mahaffy